GLP-1 Side Effects: What’s Common and When to Get Help

When you start a medicine, “some stomach upset is common” can be a frustratingly vague instruction. Does that mean a little nausea after breakfast, or a day when you cannot keep water down?

Those situations need different responses.

GLP-1-based medicines can cause digestive symptoms, particularly around starting treatment or increasing a dose. Some symptoms are manageable; others need prompt assessment. This guide focuses on recognizing the difference, with examples from semaglutide and tirzepatide. Your own product’s Medication Guide remains the reference for its specific risks.

Common does not mean you have to put up with it

Nausea, vomiting, diarrhea, constipation, and abdominal discomfort appear in the prescribing information for both Wegovy and Zepbound. Frequency and severity differ between people and products. Wegovy information; Zepbound information.

Tell your care team if symptoms interfere with eating, drinking, sleep, or ordinary activities. You do not need to wait until something becomes an emergency to ask for help.

A brief description is useful: when the symptom started, whether a dose changed recently, how often it happens, and whether you can eat and drink. “Nausea” alone gives less information than “I have felt sick after every meal since the increase and have barely managed fluids today.”

Smaller meals may help mild symptoms

When nausea is mild, smaller portions and eating more slowly may be easier than a large meal. Rich or fatty foods may be harder to tolerate. For constipation, fluids and a gradual increase in fiber can be useful, depending on your health and symptoms.

The joint nutrition advisory for GLP-1 treatment discusses these approaches, while emphasizing early contact with the prescribing team when symptoms develop. They are supportive measures, not a substitute for assessing severe or persistent symptoms.

Ask before adding laxatives, anti-nausea medicines, or supplements. Your medical history and other medicines affect what is appropriate. Do not accelerate a dose increase or change the schedule yourself.

Symptoms that need prompt medical attention

Severe abdominal pain that does not go away, especially if it spreads toward the back, needs urgent assessment. Wegovy and Zepbound Medication Guides advise stopping the medicine and calling the healthcare provider right away for this pattern because it can indicate pancreatitis.

Upper abdominal pain with fever, yellowing of the skin or eyes, or pale stools can signal a gallbladder problem. Contact a healthcare professional promptly.

Repeated vomiting or diarrhea, inability to keep fluids down, much less urination, or marked dizziness should not be dismissed as routine adjustment. Fluid loss can become serious. Seek urgent care if symptoms are severe or you cannot reach your clinician.

These patterns are described in the product information linked above and in MedlinePlus’s semaglutide patient guidance. You do not need to diagnose the cause before seeking help.

When to seek emergency help

Trouble breathing, swelling of the tongue or throat, collapse, or a severe allergic reaction requires emergency help. In the United States, call 911.

Low blood glucose is another concern, especially when a GLP-1-based medicine is used with insulin or a sulfonylurea. Ask your diabetes team for a plan before symptoms occur. Shakiness, sweating, confusion, or unusual weakness may be warning signs. Seizure or loss of consciousness needs emergency treatment. If a prescribed glucagon rescue medicine is available, someone trained to use it should follow your emergency plan and call 911. NIDDK guidance on low blood glucose.

A few symptoms and situations deserve their own conversation

Report new vision changes, a neck lump, persistent hoarseness, or swallowing difficulty promptly. These are among the concerns addressed in the product guides; they should not be explained away as ordinary stomach side effects.

Tell a surgery or procedure team that you take the medicine, including before anesthesia or deep sedation. Do not choose your own stopping interval. The team needs to plan around your treatment and procedure.

For Wegovy or Zepbound being used for weight management, the labels instruct patients to stop treatment when pregnancy is recognized and contact the healthcare provider. A future pregnancy plan belongs in the conversation before treatment as well.

Leave follow-up with a usable plan

Before the next dose change, know how to reach the clinical team and what to do outside office hours. Ask which symptoms should trigger a call and which should send you directly for urgent help.

For mild symptoms, the plan might include food changes and closer follow-up. For more serious problems, it may involve a different treatment decision. The goal is care you can safely live with—not proving how much discomfort you can tolerate.